Der skete ingen betydelig ændring i tenofovirs farmakokinetik hos probander med nedsat leverfunktion, hvilket tyder på, at det ikke er nødvendigt at justere dosis hos disse personer.
Tenofovir pharmacokinetics were not substantially altered in subjects with hepatic impairment suggesting that no dose adjustment is required in these subjects.